Kenji Yamaoka Tomokazu Kawaoka Hiroshi Aikata Yuwa Ando Yumi Kosaka Yosuke Suehiro Yasutomo Fujii Shinsuke Uchikawa Kei Morio Hatsue Fujino Takashi Nakahara Eisuke Murakami Masami Yamauchi Masataka Tsuge Akira Hiramatsu Michio Imamura Shoichi Takahashi Yoshihiro Saeki Shintaro Kuroda Tsuyoshi Kobayashi Hideki Ohdan Yoshihiro Miyata Morihito Okada Kazuaki Chayama
10.2169/internalmedicine.5870-20
Intern Med
2021;60(13):2047-2053.
conversion therapy hepatocellular carcinoma regorafenib
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34193774/
Antineoplastic Agents / therapeutic use Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy
Antineoplastic Agents / therapeutic use Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy Case Reports Aged Humans Male Phenylurea Compounds / therapeutic use Pyridines Sorafenib / therapeutic use Antineoplastic Agents Phenylurea Compounds Pyridines regorafenib Sorafenib
PMC8313913
34193774
Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib
2021